Medexus Pharmaceuticals Inc (CVE:MDP) (OTCQX:MEDXF) CEO Ken d’Entremont tells Proactive its fiscal third quarter results revealed record quarterly revenue of C$31.5M, nearly doubling its revenue year-over-year from C$16.2M in the same period in 2019. d’Entremont added given significant share price appreciation in the quarter, the non-cash fair value of the derivative associated with the conversion rights of existing debentures increased materially to C$16.5 million, the primary driver for the reported net loss of C$17.1M compared to C$2.6M.
Medexus Pharmaceuticals reveals record quarterly revenue of C$31.5M
